Zelnorm (tegaserod), a new drug for irritable bowel syndrome

August 2002

Novartis will soon market Zelnorm (tegaserod), a new drug for irritable bowel syndrome.

Zelnorm is the first in a new class...5-HT4 serotonin partial agonist. It STIMULATES bowel motility to reduce abdominal pain...bloating...and constipation. It's for CONSTIPATION-predominant IBS.

This is different from Lotronex, which is a 5-HT3 serotonin antagonist that SLOWS bowel motility...for DIARRHEA-predominant IBS.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

hormone replacement therapy
Women's Health oral contraceptives DON'T increase the risk of breast cancer
Cholesterol Some drug reps are creating confusion about changes to the Zocor (simvastatin) package insert
Cholesterol new brand of lovastatin called Altocor
Diabetes Glucophage or Precose to PREVENT type 2 diabetes
Gastroenterology Zelnorm (tegaserod), a new drug for irritable bowel syndrome
Geodon IM is now the first INJECTABLE atypical antipsychotic
new ways to treat cluster headache
Dermatology muscle and joint pain in adolescents taking Accutane (isotretinoin)
Infectious Diseases You can now get MMR and tetanus vaccines again
Infectious Diseases long-term HIV drug side effects are becoming a huge problem
Neurology & Pain Certain ethnic groups are still using the NSAID metamizole for pain and fever
Pediatrics Ritalin LA, a new ONCE-DAILY methylphenidate capsule
Pediatrics There's now an alternative to Rx EMLA cream called ELA-Max
inhaled steroids for treating persistent asthma in CHILDREN

Zelnorm (tegaserod), a new drug for irritable bowel syndrome

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents